NCT06572150

Brief Summary

The goal of this study is to learn if Deep Brain Stimulation (DBS) surgery can be streamlined for patients being treated for Parkinson's disease. The main questions it aims to answer are:

  • Can a streamlined DBS surgery protocol with minimal electrophysiology and imaging (MiXT) safely replace the current use of intraoperative electrophysiology?
  • Are we able to improve the efficiency, lower the invasiveness, and improve the clinical outcomes for patients undergoing DBS surgery? Researchers will compare patients undergoing DBS surgery with this streamlined protocol to patients who previously underwent DBS surgery with the standard protocol to see if the accuracy, clinical outcomes, and efficiency improve. Participants will undergo the standard protocol for DBS work-up and follow-up, but with minimal intraoperative electrophysiological testing.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P75+ for not_applicable parkinson-disease

Timeline
29mo left

Started Oct 2025

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Oct 2025Oct 2028

First Submitted

Initial submission to the registry

August 23, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 26, 2024

Completed
1.1 years until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

February 12, 2025

Status Verified

February 1, 2025

Enrollment Period

2 years

First QC Date

August 23, 2024

Last Update Submit

February 10, 2025

Conditions

Keywords

Deep Brain StimulationMotor evoked potentials

Outcome Measures

Primary Outcomes (1)

  • Accuracy of implanted electrode position

    The distance between the final implanted electrode and the planned electrode, as measured on imaging software.

    Intraoperative

Secondary Outcomes (5)

  • Change in disease score units on the Unified Parkinson's Disease Rating Scale

    Baseline, 12 months

  • Change in disease score units on the Parkinsons Disease Questionnaire

    Baseline, 12 months

  • Efficiency of Surgery

    Intraoperative

  • Intraoperative intensity of stimulation in milliampere

    Intraoperative

  • Safety of streamlined protocol

    4, 16, and 52 weeks post-surgery

Study Arms (2)

Minimal Intraoperative Electrophysiology

EXPERIMENTAL

Participants undergoing DBS for the diagnosis of Parkinson's disease

Procedure: Deep Brain Stimulation - Minimal Electrophysiology

Standard Intraoperative Electrophysiology

OTHER

Participants who previously underwent DBS surgery for the diagnosis of Parkinson's disease

Procedure: Deep Brain Stimulation - Standard

Interventions

Participants will undergo standard work-up and follow-up for DBS, but with minimal intraoperative electrophysiological testing.

Minimal Intraoperative Electrophysiology

Participants underwent DBS surgery with standard intraoperative electrophysiological testing.

Standard Intraoperative Electrophysiology

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient qualifying for deep brain stimulation for the diagnosis of Parkinson's disease
  • Informed consent

You may not qualify if:

  • Lack of consent
  • Electrical or other devices that preclude the performance of magnetic resonance imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth Health Science Centre

Halifax, Nova Scotia, B3H 3A7, Canada

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Lutz Weise, MD, PhD

    Nova Scotia Health Authority

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lutz Weise, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2024

First Posted

August 26, 2024

Study Start

October 1, 2025

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2028

Last Updated

February 12, 2025

Record last verified: 2025-02

Locations